Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcohol Use Disorder

In brief

The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.

Key facts

Study ID

NCT06545916

Run by

Knoa Pharma LLC

People needed

209

Starts

2024-10-14

Expected to finish

2026-05-05

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Belmont Medical Office — Brooklyn, New York, United States
• Ohio Clinical Trials — Columbus, Ohio, United States
• Inquest Clinical Research — Baytown, Texas, United States
• Cebis Usa, Llc — Houston, Texas, United States
• Bio Terra Med SRL — Bucharest, Romania
• Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila" — Bucharest, Romania
• Cabinet Medical Individual Dr. Andreea Popa — Bucharest, Romania

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.